- Home
- LGHL vs TCBP Comparison
LGHL vs TCBP Comparison
Compare LGHL & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGHL
- TCBP
- Stock Information
- Founded
- LGHL 2015
- TCBP 2013
- Country
- LGHL Singapore
- TCBP United Kingdom
- Employees
- LGHL N/A
- TCBP 41
- Industry
- LGHL Investment Bankers/Brokers/Service
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LGHL Finance
- TCBP Health Care
- Exchange
- LGHL Nasdaq
- TCBP Nasdaq
- Market Cap
- LGHL 4.3M
- TCBP 3.3M
- IPO Year
- LGHL N/A
- TCBP 2022
- Fundamental
- Price
- LGHL $0.14
- TCBP $0.35
- Analyst Decision
- LGHL
- TCBP Strong Buy
- Analyst Count
- LGHL 0
- TCBP 1
- Target Price
- LGHL N/A
- TCBP $2.40
- AVG Volume (30 Days)
- LGHL 2.7M
- TCBP 889.4K
- Earning Date
- LGHL 02-11-2025
- TCBP 11-25-2024
- Dividend Yield
- LGHL N/A
- TCBP N/A
- EPS Growth
- LGHL N/A
- TCBP N/A
- EPS
- LGHL N/A
- TCBP N/A
- Revenue
- LGHL $13,659,110.00
- TCBP N/A
- Revenue This Year
- LGHL N/A
- TCBP N/A
- Revenue Next Year
- LGHL N/A
- TCBP N/A
- P/E Ratio
- LGHL N/A
- TCBP N/A
- Revenue Growth
- LGHL 11.35
- TCBP N/A
- 52 Week Low
- LGHL $0.13
- TCBP $0.25
- 52 Week High
- LGHL $1.55
- TCBP $32.70
- Technical
- Relative Strength Index (RSI)
- LGHL 42.74
- TCBP 34.95
- Support Level
- LGHL $0.14
- TCBP $0.27
- Resistance Level
- LGHL $0.18
- TCBP $0.41
- Average True Range (ATR)
- LGHL 0.02
- TCBP 0.05
- MACD
- LGHL -0.00
- TCBP 0.02
- Stochastic Oscillator
- LGHL 21.49
- TCBP 31.19
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.